Corvus Pharmaceuticals Inc Share Price

NASDAQ: CRVS

Small Cap

$5.76

-0.12

(-2.04%)

as on September 17, 2025 at 1:29 am IST

$₹

Corvus Pharmaceuticals Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$5.7
Day's Price Range
$5.98
$5.76
1.04%
Downside
3.82%
Upside
52 Week's Low
52 Week's High
$2.54
52-Week Price Range
$10
$5.76
55.90%
Downside
73.61%
Upside

Corvus Pharmaceuticals Inc share price movements today

Previous Close: $5.88
Open: $5.86
Volume: 633.9K
Day's Low - High: $5.7 - $5.98
52 Week Low - High: $2.54 - $10

Corvus Pharmaceuticals Inc Historical Returns

1 Month Return: + 8.29 %
3 Month Return: + 38.03 %
1 Year Return: + 1.73 %
3 Year Return: + 537.47 %
5 Year Return: + 35.17 %

Corvus Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Corvus Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$434.4M

EPS (TTM)

-0.135

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-35.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Corvus Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corvus Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Corvus Pharmaceuticals Inc	BUY	$434.4M	35.17%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Corvus Pharmaceuticals Inc Stock including INR - Dollar returns

The Corvus Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Corvus Pharmaceuticals Inc investment value today

Current value as on today

₹1,04,521

Returns

₹4,521

(+4.52%)

Returns from Corvus Pharmaceuticals Inc Stock

₹346 (-0.35%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Corvus Pharmaceuticals Inc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Corvus Pharmaceuticals Inc. Average target price of $15.75

Corvus Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Corvus Pharmaceuticals Inc.

What analysts predicted

63.43%UPSIDE

Target Price

$15.75

Current Price

$5.76

Analyzed by

10 Analysts

Target

$15.75

Corvus Pharmaceuticals Inc target price $15.75, a slight upside of 63.43% compared to current price of $5.76. According to 10 analysts rating.

Corvus Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Corvus Pharmaceuticals Inc Stock has increased by 70% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:70% versus previous 30 day period

Corvus Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-6	-5	-5	-5	-6	-5	-7	-8	-9	-10
EBITDA	-6	-5	-5	-5	-6	-5	-7	-8	-9	-10
Interest Expense	0	0	0	0	0	0	0	-	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-6	-6	-6	-5	-4	-40	-12	15	-7
Income Tax Expense	0	0	0	0	0	-	-	-	-	-
Net Income	-8	-6	-6	-6	-5	-4	-40	-12	15	-7
Net Profit Margin	0.00%	0.00%	0.00%	-2704.47%	0.00%	0.00%	0.00%	-13764.77%	0.00%	0.00%

Corvus Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-13	-36	-56	-49	-48	-43	-38	-32	-23	-27
EBITDA	-31	-36	-55	-48	-48	-43	-42	-40	-26	-27
Interest Expense	-	0	-	2	2	0	0	0	1	1
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-31	-36	-55	-46	-46	-5	-43	-41	-27	-62
Income Tax Expense	0	0	0	2	-2	-1	-5	8	-	-
Net Income	-31	-36	-55	-46	-43	-4	-43	-41	-27	-62
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Corvus Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-6	-6	-6	-5	-4	-40	-12	15	-7
Operating Cash Flow	-5	-5	-5	-5	-5	-6	-8	-8	-5
Investing Cash Flow	-4	17	-2	0	-17	-3	-6	4	-20
Financing Cash Flow	7	0	-	-	30	0	18	0	35
Change in Cash	-1	12	-7	-5	7	-10	4	-3	9

Corvus Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-36	-55	-46	-46	-5	-43	-41	-27	-62
Operating Cash Flow	-27	-46	-40	-37	-34	-36	-27	-23	-25
Investing Cash Flow	-42	84	-30	3	44	21	-23	15	-27
Financing Cash Flow	71	1	65	0	1	62	0	7	49
Change in Cash	0	40	-5	-34	11	47	-50	0	-3

Global Institutional Holdings in Corvus Pharmaceuticals Inc

Funds	Holdings
Orbimed Advisors, LLC	9%
Samlyn Capital, LLC	5.27%
Adams Street Partners LLC	4.25%
Point72 Asset Management, L.P.	3.61%
RTW INVESTMENTS, LLC	3.47%

See all

Insights on Corvus Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, CRVS stock has moved up by 49.2%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CRVS has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 61.3%

About Corvus Pharmaceuticals Inc

corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.

Organisation	Corvus Pharmaceuticals Inc
Headquarters	901 Gateway Boulevard, South San Francisco, CA, United States, 94080
Industry	Health Technology
CEO	Dr. Richard A. Miller M.D.
E-voting on shares	Click here to vote

Key Management of Corvus Pharmaceuticals Inc

Name	Title
Dr. William Benton Jones Ph.D.	Senior Vice President of Pharmaceutical Development
Mr. Jeffrey S. Arcara	Senior VP & Chief Business Officer
Dr. Richard A. Miller M.D.	Co-Founder, President, CEO & Chairman of the Board
Dr. Peter A. Thompson FACP, M.D.	Co-Founder & Independent Director
Mr. Leiv Lea	Chief Financial Officer

FAQs

What is Corvus Pharmaceuticals Inc share price today?

Corvus Pharmaceuticals Inc share price today is $5.76 as on September 17, 2025 at 1:29 am IST at the close of the market. Corvus Pharmaceuticals Inc share today touched a day high of $5.98 and a low of $5.7.

What is the 52 week high and 52 week low for Corvus Pharmaceuticals Inc share?

Corvus Pharmaceuticals Inc share touched a 52 week high of $10 on November 13, 2024 and a 52 week low of $2.54 on April 9, 2025. Corvus Pharmaceuticals Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $5.76,which is 42.40% down from its 52 week high and 126.77% up from its 52 week low.

What is Corvus Pharmaceuticals Inc's market capitalisation today?

Corvus Pharmaceuticals Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Corvus Pharmaceuticals Inc Stock (CRVS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Corvus Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corvus Pharmaceuticals Inc Shares that will get you 0.2604 shares as per Corvus Pharmaceuticals Inc share price of $5.76 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Corvus Pharmaceuticals Inc Stock (CRVS) from India?

Indian investors can start investing in Corvus Pharmaceuticals Inc (CRVS) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 10:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Corvus Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 10:39 am IST). Based on Corvus Pharmaceuticals Inc share’s latest price of $5.76 as on September 17, 2025 at 1:29 am IST, you will get 1.7361 shares of Corvus Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Corvus Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Corvus Pharmaceuticals Inc stock has given 35.17% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?